UK acts on faulty prostate cancer home-testing kits
This article was originally published in Clinica
The UK's Medicines and Healthcare products Regulatory Agency today issued an alert urging all users of prostate cancer home-test screening kits manufactured by Biomerica in the last 12 months to seek medical advice. A single batch of 1,000 kits branded "Simplicity Health" or "Fortel" were the subject of a field safety notice issued by the Newport Beach, California firm to its distributors in August 2009, related to a "reduced stability" fault that posed a risk of a false negative. After recalling the faulty batch, the MHRA is now acting on concerns that users of kits may not be aware of the situation, or not able to trace the batch number.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.